4-Allyl-5-(1-(m-tolyloxy)ethyl)-4H-1,2,4-triazole-3-thiol

Catalog No. :
ACENDT897
CAS No. :
667413-68-5
Molecular Formula :
C14H17N3OS
Molecular Weight :
275.38

IUPAC Name:4-allyl-5-(1-(m-tolyloxy)ethyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione

4-Allyl-5-(1-(m-tolyloxy)ethyl)-4H-1,2,4-triazole-3-thiol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$136.00Login to see priceInquiryInquiry
1g95%$310.00Login to see priceInquiryInquiry
5g95%$910.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Allyl-5-(1-(m-tolyloxy)ethyl)-4H-1,2,4-triazole-3-thiol
IUPAC Name4-allyl-5-(1-(m-tolyloxy)ethyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione
Molecular FormulaC14H17N3OS
Molecular Weight275.38
SMILESSC1=NN=C(C(OC2=CC=CC(C)=C2)C)N1CC=C
InChI KeyCVQZLILJLNHSQL-UHFFFAOYSA-N
SynonymCHEMBRDG-BB 3018141;ART-CHEM-BB B018141;4-Allyl-5-[1-(3-methylphenoxy)ethyl]-4H-1,2,4-triazole-3-thiol;Albb-003457;4-allyl-5-[1-(3-methylphenoxy)ethyl]-4H-1,2,4-triazole-3-thiol(SALTDATA: FREE);3-[1-(3-methylphenoxy)ethyl]-4-prop-2-enyl-1H-1,2,4-triazole-5-thione;3H-1,2,4-Triazole-3-thione, 2,4-dihydro-5-[1-(3-methylphenoxy)ethyl]-4-(2-propen-1-yl)-;4-Allyl-5-(1-(m-tolyloxy)ethyl)-4H-1,2,4-triazole-3-thiol
CAS No.667413-68-5

Synthetic Route by SureRoute

1. ACENDT897 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACENDT897 route product structure diagram
    ACENDT897667413-68-5
Inquiry

2. ACENDT897 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACENDT897 route product structure diagram
    ACENDT897667413-68-5
Inquiry

Comments (0)